DJ Corbus Pharmaceuticals Holdings Inc. Stock Rises Thursday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ rallied 1.04% to $7.78 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 2.54% to 25,809.66 and the Dow Jones Industrial Average rising 1.86% to 50,848.75.
Corbus Pharmaceuticals Holdings Inc. closed 62.16% short of its 52-week high of $20.56, which the company reached on October 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Vanda Pharmaceuticals Inc. $(VNDA)$ rose 1.16% to $6.10, Fortress Biotech Inc. (FBIO) fell 0.36% to $2.76, and Viking Therapeutics Inc. (VKTX) rose 3.10% to $28.61.
Trading volume (358,319) remained 105,027 below its 50-day average volume of 463,346.
Data source: Dow Jones Market Data, FactSet. Data compiled June 11, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 11, 2026 17:22 ET (21:22 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments